Department of Urology Grand Rounds: Jeremy Archer, MD

The University of Florida Department of Urology invites you to attend Grand Rounds:

Wednesday, October 13, 2021
7:00 – 8:00 AM

“Updates in Penile Cancer: Minimally Invasive Surgery and Long-Term Follow-up”

head shot of doctor Jeremy Archer in his white doctor coat. he has on a white shirt with a blue and white striped tie.

Presenter: Jeremy Archer, MD
PGY5 – Chief Resident
University of Florida
Department of Urology


Upon completion of this activity, participants should be able to:

  1. Describe the diagnosis and treatment of penile cancer
  2. Review principles of surgery for penile cancer
  3. Present urologic complications of penile cancer surgery
  4. Review available guidelines and recent updates in surveillance after definitive surgery


Dr. Archer has disclosed that he has no relevant financial relationships. Planning committee member Vincent Bird, MD has disclosed that he is a consultant for Boston Scientific. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: All relevant financial relationships have been mitigated.


The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 


The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For additional information, contact Stephanie Stenner at 352/273-8634 or e-mail

Section # 1648

logo that reads uf college of medicine department of urology university of Florida. The letters are in dark blue and there is dark orange vertical line between the UF and the reset of the words.


Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery